Caisse de Depot et Placement du Quebec (CDPQ)
BMRN icon

Caisse de Depot et Placement du Quebec (CDPQ)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.4M Sell
945,603
-103,238
-10% -$6.02M 0.09% 252
2025
Q4 		$62.3M Buy
1,048,841
+135,678
+15% +$7.39M 0.11% 220
2025
Q3 		$49.5M Buy
913,163
+275,894
+43% +$15.8M 0.09% 223
2025
Q2 		$35M Buy
637,269
+580,402
+1,021% +$34.2M 0.07% 247
2025
Q1 		$4.02M Buy
+56,867
New +$3.83M 0.01% 483
2024
Q3 		– Sell
-2,677
Closed -$220K – 504
2024
Q2 		$220K Sell
2,677
-36,653
-93% -$3.05M ﹤0.01% 455
2024
Q1 		$3.44M Sell
39,330
-28,118
-42% -$2.52M 0.01% 402
2023
Q4 		$6.5M Buy
67,448
+22,735
+51% +$2.01M 0.02% 327
2023
Q3 		$3.96M Sell
44,713
-12,800
-22% -$1.14M 0.01% 346
2023
Q2 		$4.99M Buy
57,513
+5,130
+10% +$483K 0.01% 350
2023
Q1 		$5.09M Sell
52,383
-27,700
-35% -$2.87M 0.01% 389
2022
Q4 		$8.29M Buy
80,083
+40,300
+101% +$3.78M 0.03% 346
2022
Q3 		$3.37M Buy
39,783
+15,787
+66% +$1.41M 0.01% 406
2022
Q2 		$1.99M Sell
23,996
-7,738
-24% -$616K 0.01% 451
2022
Q1 		$2.45M Buy
31,734
+28,400
+852% +$2.38M 0.01% 490
2021
Q4 		$295K Sell
3,334
-3,095
-48% -$255K ﹤0.01% 555
2021
Q3 		$497K Buy
6,429
+1,400
+28% +$110K ﹤0.01% 505
2021
Q2 		$420K Buy
+5,029
New +$399K ﹤0.01% 478
2020
Q4 		– Sell
-2,800
Closed -$213K – 683
2020
Q3 		$213K Sell
2,800
-1,600
-36% -$162K ﹤0.01% 678
2020
Q2 		$543K Sell
4,400
-950
-18% -$94.4K ﹤0.01% 622
2020
Q1 		$452K Buy
5,350
+1,450
+37% +$125K ﹤0.01% 665
2019
Q4 		$330K Sell
3,900
-6,000
-61% -$453K ﹤0.01% 675
2019
Q3 		$667K Buy
9,900
+300
+3% +$23.1K ﹤0.01% 745
2019
Q2 		$822K Sell
9,600
-300
-3% -$25.7K ﹤0.01% 645
2019
Q1 		$879K Sell
9,900
-2,400
-20% -$222K ﹤0.01% 630
2018
Q4 		$1.05M Sell
12,300
-300
-2% -$28.5K ﹤0.01% 597
2018
Q3 		$1.22M Buy
12,600
+9,500
+306% +$948K ﹤0.01% 595
2018
Q2 		$292K Sell
3,100
-1,000
-24% -$87.6K ﹤0.01% 753
2018
Q1 		$332K Buy
4,100
+1,300
+46% +$112K ﹤0.01% 701
2017
Q4 		$250K Sell
2,800
-1,300
-32% -$113K ﹤0.01% 702
2017
Q3 		$383K Buy
4,100
+200
+5% +$17.7K ﹤0.01% 695
2017
Q2 		$353K Buy
3,900
+1,100
+39% +$100K ﹤0.01% 694
2017
Q1 		$246K Sell
2,800
-10,200
-78% -$907K ﹤0.01% 680
2016
Q4 		$1.08M Sell
13,000
-2,600
-17% -$224K ﹤0.01% 599
2016
Q3 		$1.44M Sell
15,600
-800
-5% -$75.3K ﹤0.01% 608
2016
Q2 		$1.28M Buy
16,400
+6,400
+64% +$544K ﹤0.01% 686
2016
Q1 		$825K Buy
+10,000
New +$814K ﹤0.01% 719
2013
Q3 		– Sell
-4,800
Closed -$268K – 787
2013
Q2 		$268K Buy
+4,800
New +$299K ﹤0.01% 784

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s BMRN Position: Q1 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) reduced its BioMarin Pharmaceuticals (BMRN) stake by 9.8% in Q1 2026, selling an estimated $6.02M and leaving 945,603 shares worth $53.4M. The position accounts for 0.09% of the portfolio, ranked #252.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in BMRN in Q2 2013 and has held it in 38 quarters since. The position peaked at $62.3M in Q4 2025. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Caisse de Depot et Placement du Quebec (CDPQ) held 945,603 shares of BioMarin Pharmaceuticals worth $53.4M as of Q1 2026.
  • Caisse de Depot et Placement du Quebec (CDPQ) sold 103,238 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $6.02M.
  • BioMarin Pharmaceuticals made up 0.09% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q1 2026, its #252 holding.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 38 quarters since.
  • Caisse de Depot et Placement du Quebec (CDPQ)'s BioMarin Pharmaceuticals position peaked at $62.3M in Q4 2025.
  • 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q1 2026, filed 14 May 2026.